This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Reported reason: Shortage of an active ingredient

Product Information

LISDEXAMFETAMINE 30 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $2.8306 per EA under NDC 43547060410. Its NADAC has been published 165 times since Sep 27, 2023.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 30 MG CAPSULE

Lisdexamfetamine dimesylate capsules
$2.8306per EA
DEA Schedule CII

Strength

30 mg/1

NDC

43547060410

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216266

FDA Approved

8/25/2023

TE Code

AB

On Market Since

8/26/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has been published 165 times since Sep 27, 2023, and over the history we have for it it has declined 20.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.8306 per EA
All-time high$6.5077 (Apr 10, 2024)
All-time low$2.6640 (Aug 19, 2026)
52-week high$3.4369
52-week low$2.6640
Median price$3.8019
Average price$3.9915
Largest weekly change+59.1% (Jun 19, 2024)
Weeks tracked165
Tracking sinceSep 27, 2023

Price History

1W

-1.9%

1M

+4.8%

3M

+6.3%

6M

-9.4%

1Y

-17.6%

3Y

-28.2%

5Y

N/A

All

-20.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lisdexamfetamine dimesylate capsules market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $2.8306 per EA (NDC 43547060410), effective Nov 18, 2026.

How has the price of LISDEXAMFETAMINE 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has declined 20.6%. It has been tracked across 165 weekly CMS publications since Sep 27, 2023.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG CAPSULE?

Since Sep 27, 2023, the NADAC for LISDEXAMFETAMINE 30 MG CAPSULE has ranged from a low of $2.6640 (Aug 19, 2026) to a high of $6.5077 (Apr 10, 2024), with a median of $3.8019 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of LISDEXAMFETAMINE 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LISDEXAMFETAMINE 30 MG CAPSULE?

LISDEXAMFETAMINE 30 MG CAPSULE (NDC 43547060410) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 30 MG CAPSULE in shortage?

Yes — NDC 43547060410 is currently listed in FDA's drug shortage database (posted Jul 14, 2023). Reported reason: Shortage of an active ingredient.